All posts by: Michael Zand

About Michael Zand

Powerful Data Potentiates Rapid EU Market Approval For Tigenix Stem Cell Therapies – Seeking Alpha

Continue reading

2017-12-12 NEWS

Seeking Alpha

Powerful Data Potentiates Rapid EU Market Approval For Tigenix Stem Cell Therapies
Seeking Alpha
Their lead candidate, Cx601, now known in the EU market as Alofisel, is an adipose derived stem cell product designed to treat Crohn’s disease related fistulas. They have recently seen success associated with their lead product and are expecting a CHMP
ETHICS AND RESEACRCH VERSUS EMBRYONIC STEM CELLCheckbiotech.org (press release)

all 3 news articles »